Background and aims Obesity has been suggested as a possible risk factor for a more
severe course of COVID-19; however, conclusive evidence is lacking and few studies have …

You're a researcher seeking to understand the effect of exposure X on outcome Y in disease
group Z. Hundreds, if not thousands, of articles have been published reporting a harmful …

OBJECTIVE Diabetes is the leading cause of nontraumatic lower-limb amputations in the
US, but no research has prospectively examined associations between limb-specific …

Background Systematic screening and treatment of sleep-disordered breathing (SDB) or
obstructive sleep apnea (OSA) in presurgical patients would impose a significant cost …

High cardiovascular mortality is well documented in lean phenotypes exhibiting visceral fat
accumulation. In contrast, corpulent phenotypes with predominantly subcutaneous fat …

Much has been published on the characteristics of type 2 diabetes mellitus and its
association with the epidemic of obesity. But relatively little is known about the incidence of …

Background Metabolic-associated fatty liver disease (MAFLD) encompasses diverse
disease groups with potentially heterogeneous clinical outcomes. We investigated the risk of …

Background:“Obesity paradox” refers to an association between obesity and reduced
mortality (contrary to an expected increased mortality). A common explanation is collider …

Class I obesity conveys an increased risk of comorbidities, impairs physical and mental
health-related quality of life, and it is associated to an increased psychosocial burden …

Background: Many studies have documented an obesity paradox—a survival advantage of
being obese—in populations diagnosed with a medical condition. Whether obesity is …